Notalgia Paresthetica (NP) Case Study

Click here for a PDF version of this case study

PPP rescue case study

 

Study Characteristics

  • Study Phase: II
  • Patient Population: 126 patients with Notalgia Paresthetica (NP) (Pruritus associated with NP)
  • IP Route of Administration: Systemic (oral)
  • Site Distribution: 33 sites (USA and Canada)
  • Study Procedures: Photographs, Pharmacokinetics, Electrocardiograms

 


 

Study Challenges

  • Patient awareness: Challenge in advertisement as patients are often unaware of the name of their condition
  • Run-in period (screening): To ensure the enrollment of highly compliant patients and those with consistent itch
  • Patient compliance: Primary endpoints were relying on patient-reported assessments
  • Uncommon indication: PI with little experience in this indication

 


 

Study Highlights

Site engagement Increased support for low-performing sites

Engaged with low-enrolling sites to ensure proper use of their local campaign budget

Phone interview icon Creative advertising

Digital and local innovative marketing tactics to encourage patients to participate

Dermatology Investigator Icon Notalgia paresthetica cro specialty

Innovaderm managed 100% of the notalgia paresthetica studies (as per clinical trials.gov)

Dermatology Investigator Icon High compliance rate

Additional patient compensation for fully completed diary

Contact us


Newsletter

Join our science community with Press Forward, our quarterly newsletter. Get the latest in dermatology clinical research. Subscribe now!

Newsletter subscription resources

*By subscribing to our newsletter, you acknowledge and agree to the terms of our privacy policy.

Innovaderm Research Wave